Efficient transduction of early passage human melanoma to secrete IL-4

Apperly, 1991, Retroviral-mediated gene transfer of human adenosine deaminase into murine hematopoietic cells, Semin. Hematol., 28, 170 Berd, 1990, Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients, J. Clin. Oncol., 8, 1858, 10.1200/JCO.1990.8.11.1858 Blankenstein, 1991, Cytokines and cancer: experimental systems, Curr. Opin. Immunol., 3, 694, 10.1016/0952-7915(91)90098-L Bosco, 1990, Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory, J. Immunol., 145, 3136, 10.4049/jimmunol.145.9.3136 Chang, 1993, Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro, Cancer Res., 53, 1043 Dhawan, 1991, Systemic delivery of human growth hormone by injection of genetically engineered myoblasts, Science, 254, 1509, 10.1126/science.1962213 Dranoff, 1993, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity, 90, 3539 Fernandez-Botran, 1986, B cell stimulatory factor-1 (BSF-1) promotes growth of helper T cell lines, J. Exp. Med., 164, 580, 10.1084/jem.164.2.580 Gansbacher, 1992, Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-γ in irradiated human melanoma cells, Blood, 80, 2817, 10.1182/blood.V80.11.2817.2817 Geiger, 1993, Generation of T cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastases, J. Immunother., 13, 153, 10.1097/00002371-199304000-00002 Golumbek, 1991, Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4, Science, 254, 713, 10.1126/science.1948050 Harlow, 1988, Antibodies, A Laboratory Manual, 563 Hewitt, 1976, A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin, Br. J. Cancer, 33, 241, 10.1038/bjc.1976.37 Houghton, 1982, Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets, J. Exp. Med., 156, 1755, 10.1084/jem.156.6.1755 Howard, 1982, Identification of a T cell-derived B cell growth factor distinct from interleukin-2, J. Exp. Med., 155, 914, 10.1084/jem.155.3.914 Howard, 1994, Retrovirus-mediated gene transfer of the human γ-IFN gene: a therapy for cancer, Ann. NY Acad. Sci., 716, 167, 10.1111/j.1749-6632.1994.tb21711.x Jaffee, 1993, High efficiency gene transfer into primary human tumor explants without cell selection, Cancer Res., 53, 2221 Krauss, 1991, An in vivo animal model of gene therapy for leukocyte adhesion deficiency, J. Clin. Invest., 88, 1412, 10.1172/JCI115448 Krauss, 1994, Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate IL-4, J. Immunotherapy, 16, 77, 10.1097/00002371-199408000-00001 Kuhn, 1991, Generation and analysis of interleukin 4 deficient mice, Science, 254, 707, 10.1126/science.1948049 Melani, 1994, Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells, Nat. Immun., 13, 76 Miller, 1993, Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2, Blood, 82, 3686, 10.1182/blood.V82.12.3686.3686 Paul, 1991, Interleukin-4: a prototypic immunoregulatory lymphokine, Blood, 77, 1859, 10.1182/blood.V77.9.1859.1859 Real, 1985, Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues, Cancer Res., 45, 4401 Sambrook, 1989 Schreiber, 1993, Recombinant retroviruses containing novel reporter genes, BioTechniques, 14, 818 Shu, 1987, Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy, J. Immunol., 139, 295, 10.4049/jimmunol.139.1.295 Siegel, 1990, A bioassay for the measurement of human interleukin-4, J. Immunol. Methods, 132, 287, 10.1016/0022-1759(90)90040-3 Spits, 1987, Recombinant interleukin 4 promotes the growth of human T cells, J. Immunol., 139, 1142, 10.4049/jimmunol.139.4.1142 Spits, 1988, IL-4 inhibits IL-2 mediated induction of human lymphokine activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed lymphocyte cultures, J. Immunol., 141, 29, 10.4049/jimmunol.141.1.29 Tepper, 1989, Murine interleukin-4 displays potent anti-tumor activity in vivo, Cell, 57, 503, 10.1016/0092-8674(89)90925-2 Uchiyama, 1993, Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response, Cancer Res., 53, 949 Varmus, 1988, Retroviruses, Science, 240, 1427, 10.1126/science.3287617 Yannelli, 1993, Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor a (TNF-a) or interleukin-2 (IL-2), J. Immunol. Methods, 161, 77, 10.1016/0022-1759(93)90199-H Yokota, 1986, Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell- stimulating activities, 83, 5894